Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium

Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
doi: https://doi.org/10.1101/2023.12.14.23298578

Article usage

Article usage: December 2023 to December 2024

AbstractFullPdf
Dec 2023114518
Jan 202456412
Feb 20244228
Mar 20242646
Apr 20242156
May 20242817
Jun 202421310
Jul 202427214
Aug 20241305
Sep 202416611
Oct 20241655
Nov 202420710
Dec 20241328
Back to top
Posted December 18, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium
Myriam Drysdale, Thor Hautekiet, Moushmi Singh, Joris Hautekiet, Linda Ludikhuyze, Vishal Patel, Daniel C Gibbons, Dorothée De Roeck, Kirsten Colpaert, Emily J Lloyd, Eva Van Braeckel
medRxiv 2023.12.14.23298578; doi: https://doi.org/10.1101/2023.12.14.23298578
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area